Skip to main content

TRV

Stock
Financials
Insurance - Property & Casualty

Performance overview

TRV Price
Price Chart

Forward-looking statistics

Beta
—
Risk
—

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Travelers offers a broad product range and participates in both commercial and personal insurance lines. Its commercial operations offer a variety of coverage types for companies of any size but concentrate on serving midsize businesses. Its personal lines are roughly evenly split between auto and homeowners insurance. Travelers derives 6% of its premiums from foreign markets.

Company info

SectorFinancials
IndustryInsurance - Property & Casualty
Employees36K
Market cap$48.8B

Fundamentals

Enterprise value$63.5B
Revenue$47.0B
Revenue per employee—
Profit margin9.09%
Debt to equity28.50

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$18.36
Dividend per share$4.20
Revenue per share$206.64
Avg trading volume (30 day)$310M
Avg trading volume (10 day)$271M
Put-call ratio—

Macro factor sensitivity

Growth+2.3
Credit+0.9
Liquidity-0.0
Inflation+0.5
Commodities-0.2
Interest Rates-1.3

Valuation

Dividend yield1.62%
PEG Ratio12.33
Price to sales1.26
P/E Ratio12.33
Enterprise Value to Revenue1.35
Price to book2.11

Upcoming events

Next earnings dayApril 16, 2025
Next dividend day—
Ex. dividend dayJune 10, 2025

News

Travelers (TRV) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Travelers (TRV) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research (July 17, 2025)
Travelers Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

The Travelers Companies, Inc. TRV will release earnings results for the second quarter, before the opening bell on Thursday, July 17.

Benzinga (July 16, 2025)
Wall Street Analysts Predict a 231.05% Upside in Trevi Therapeutics (TRVI): Here's What You Should Know

The mean of analysts' price targets for Trevi Therapeutics (TRVI) points to a 231.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research (July 11, 2025)
Travelers (TRV) Earnings Expected to Grow: Should You Buy?

Travelers (TRV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research (July 10, 2025)
The Setup: ASML, Travelers, American Express and Netflix

The Investment Committee give you the setup on some key stocks reporting this week.

CNBC Television (April 14, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free